The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
5
- 1
Whitmire, Jason Daniel
Investor born in March 1971Individual (5 offsprings)Officer
2024-02-29 ~ nowOF - Director → CIF 0 - 2
Kotter, Mark Reinhard, Dr
Scientist, Medical Doctor born in February 1971Individual (6 offsprings)Officer 2020-09-28 ~ nowOF - Director → CIF 0Dr Mark Reinhard Kotter
Born in February 1971Individual (6 offsprings)Person with significant control 2020-09-28 ~ nowPE - Ownership of shares – More than 25% but not more than 50% → CIF 0PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0 - 3
Boehler, Michael Karl, Dr
Chief Business Officer born in March 1970Individual (1 offspring)Officer 2025-07-25 ~ nowOF - Director → CIF 0 - 4
Gstoettner, Markus
Chief Executive Officer born in August 1986Individual (2 offsprings)Officer 2024-02-29 ~ nowOF - Director → CIF 0 - 5
Romanowski, Piotr, Dr
Director born in November 1969Individual (1 offspring)Officer 2025-07-07 ~ nowOF - Director → CIF 0
Ceased
3
- 1
Schuster, Florian
Financial Director born in August 1975Individual (2 offsprings)Officer 2020-09-28 ~ 2024-04-18OF - Director → CIF 0Mr Florian Schuster
Born in August 1975Individual (2 offsprings)Person with significant control 2020-09-28 ~ 2021-12-29PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0PE - Ownership of shares – More than 25% but not more than 50% → CIF 0 - 2
Ives, Daniel Jeremy
Ceo Scientist born in September 1986Individual (2 offsprings)Officer 2020-09-28 ~ 2021-05-26OF - Director → CIF 0 - 3
Klemen, Bernhard, Dr
Director born in July 1984IndividualOfficer 2022-09-08 ~ 2024-04-18OF - Director → CIF 0Dr. Bernhard Klemen
Born in July 1984IndividualPerson with significant control 2020-09-28 ~ 2021-12-29PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
Company in focus
CLOCK BIO LIMITED
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
52024-01-01 ~ 2024-12-31
32023-01-01 ~ 2023-12-31
Intangible Assets
43,155 GBP2024-12-31
Property, Plant & Equipment
12,520 GBP2024-12-31
2,999 GBP2023-12-31
Fixed Assets - Investments
30,344 GBP2024-12-31
Fixed Assets
86,019 GBP2024-12-31
2,999 GBP2023-12-31
Debtors
Current
660,718 GBP2024-12-31
127,579 GBP2023-12-31
Cash at bank and in hand
2,753,797 GBP2024-12-31
1,084,000 GBP2023-12-31
Current Assets
3,414,515 GBP2024-12-31
1,211,579 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-117,769 GBP2024-12-31
Net Current Assets/Liabilities
3,296,746 GBP2024-12-31
-2,090,431 GBP2023-12-31
Total Assets Less Current Liabilities
3,382,765 GBP2024-12-31
-2,087,432 GBP2023-12-31
Net Assets/Liabilities
3,382,765 GBP2024-12-31
-2,087,432 GBP2023-12-31
Equity
Called up share capital
21 GBP2024-12-31
10 GBP2023-12-31
10 GBP2023-01-01
Share premium
7,611,977 GBP2024-12-31
41,725 GBP2023-12-31
41,725 GBP2023-01-01
Retained earnings (accumulated losses)
-4,229,233 GBP2024-12-31
-2,129,167 GBP2023-12-31
-693,016 GBP2023-01-01
Equity
3,382,765 GBP2024-12-31
-2,087,432 GBP2023-12-31
-651,281 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
-2,100,066 GBP2024-01-01 ~ 2024-12-31
-1,436,151 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-2,100,066 GBP2024-01-01 ~ 2024-12-31
-1,436,151 GBP2023-01-01 ~ 2023-12-31
Issue of Equity Instruments
Called up share capital
11 GBP2024-01-01 ~ 2024-12-31
Issue of Equity Instruments
7,570,263 GBP2024-01-01 ~ 2024-12-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
44,400 GBP2024-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
1,245 GBP2024-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
43,155 GBP2024-12-31
Property, Plant & Equipment - Gross Cost
Office equipment
14,140 GBP2024-12-31
5,997 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Office equipment
2,998 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Office equipment, Owned/Freehold
3,286 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
1,620 GBP2024-12-31
Property, Plant & Equipment
Office equipment
12,520 GBP2024-12-31
2,999 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
133,180 GBP2024-12-31
Other Debtors
Current
488,510 GBP2024-12-31
44,042 GBP2023-12-31
Prepayments/Accrued Income
Current
39,028 GBP2024-12-31
83,537 GBP2023-12-31
Trade Creditors/Trade Payables
Current
22,594 GBP2024-12-31
108,716 GBP2023-12-31
Taxation/Social Security Payable
Current
16,680 GBP2024-12-31
1,633 GBP2023-12-31
Other Creditors
Current
3,067,292 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
78,495 GBP2024-12-31
124,369 GBP2023-12-31
Creditors
Current
117,769 GBP2024-12-31
3,302,010 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
163,317 shares2024-12-31
163,317 shares2023-12-31
Par Value of Share
Class 1 ordinary share
0.000012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
1,004,072 shares2024-12-31
800,000 shares2023-12-31
Par Value of Share
Class 2 ordinary share
0.000012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
407,325 shares2024-12-31
Par Value of Share
Class 3 ordinary share
0.000012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
504,121 shares2024-12-31
Par Value of Share
Class 4 ordinary share
0.000012024-01-01 ~ 2024-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
39,813 GBP2024-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
39,813 GBP2024-12-31
- Registered number 12909273
CLOCK BIO LIMITED
Info
Salisbury House, Station Road, Cambridge CB1 2LAPrivate Limited Company incorporated on 2020-09-28 (5 years). The company status is Active.The last date of confirmation statement was made at 2024-09-27CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 26 August 2025 and
licensed under the Open Government Licence v3.0.